Last reviewed · How we verify
C: M207 3.8 mg, 1 hr, upper arm
C: M207 3.8 mg, 1 hr, upper arm is a Small molecule drug developed by Zosano Pharma Corporation. It is currently in Phase 1 development. Also known as: C: Zolmitriptan patch, 3.8 mg, 1 hour, upper arm.
At a glance
| Generic name | C: M207 3.8 mg, 1 hr, upper arm |
|---|---|
| Also known as | C: Zolmitriptan patch, 3.8 mg, 1 hour, upper arm |
| Sponsor | Zosano Pharma Corporation |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- C: M207 3.8 mg, 1 hr, upper arm CI brief — competitive landscape report
- C: M207 3.8 mg, 1 hr, upper arm updates RSS · CI watch RSS
- Zosano Pharma Corporation portfolio CI
Frequently asked questions about C: M207 3.8 mg, 1 hr, upper arm
What is C: M207 3.8 mg, 1 hr, upper arm?
C: M207 3.8 mg, 1 hr, upper arm is a Small molecule drug developed by Zosano Pharma Corporation.
Who makes C: M207 3.8 mg, 1 hr, upper arm?
C: M207 3.8 mg, 1 hr, upper arm is developed by Zosano Pharma Corporation (see full Zosano Pharma Corporation pipeline at /company/zosano-pharma-corporation).
Is C: M207 3.8 mg, 1 hr, upper arm also known as anything else?
C: M207 3.8 mg, 1 hr, upper arm is also known as C: Zolmitriptan patch, 3.8 mg, 1 hour, upper arm.
What development phase is C: M207 3.8 mg, 1 hr, upper arm in?
C: M207 3.8 mg, 1 hr, upper arm is in Phase 1.
Related
- Manufacturer: Zosano Pharma Corporation — full pipeline
- Also known as: C: Zolmitriptan patch, 3.8 mg, 1 hour, upper arm
- Compare: C: M207 3.8 mg, 1 hr, upper arm vs similar drugs
- Pricing: C: M207 3.8 mg, 1 hr, upper arm cost, discount & access